Will Viridian Therapeutics Inc (VRDN) Stay at the Top of the Healthcare Sector?

Viridian Therapeutics Inc (VRDN) is near the top in its sector according to InvestorsObserver. VRDN gets an overall rating of 82. That means it scores higher than 82% of stocks. Viridian Therapeutics Inc gets a 98 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

VRDN has an Overall Score of 82. Find out what this means to you and get the rest of the rankings on VRDN!

See Full VRDN Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 82 means the stock is more attractive than 82 percent of stocks. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Viridian Therapeutics Inc Stock Today?

Viridian Therapeutics Inc (VRDN) stock is up 2.4% while the S&P 500 is lower by -0.41% as of 3:25 PM on Wednesday, Aug 31. VRDN is higher by $0.52 from the previous closing price of $21.70 on volume of 236,327 shares. Over the past year the S&P 500 is lower by -12.23% while VRDN is higher by 66.07%. VRDN lost -$4.60 per share the over the last 12 months. Click Here to get the full Stock Report for Viridian Therapeutics Inc stock.